PAhR Therapeutics

Pahr Therapeutics is a clinical stage company focused on developing novel mechanisms for the treatment of pulmonary arterial hypertension (PAH).

Domain
Healthcare
Status
Current Private Investment
Stage of Initial Investment
NewCo
Initial Investment Year
2025
P Ah R Portco Hover Image